Capital Research Global Investors / ABBV
Capital Research Global Investors’s Abbvie Inc Position
Does Capital Research Global Investors own Abbvie Inc (ABBV)? Yes — 31.25M shares worth $6.8B (+1.05% of its 13F portfolio) as of Q1 2026, up from 25.41M shares the prior filed quarter.
Position Value
$6.8B
Q1 2026
Shares
31.25M
% of Portfolio
+1.05%
Quarters Held
30
currently held
Position History ABBV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 31.25M | $6.8B | +1.05% |
| Q4 2025 | 25.41M | $5.8B | +1.07% |
| Q3 2025 | 25.23M | $5.8B | +1.10% |
| Q2 2025 | 25.27M | $4.7B | +0.94% |
| Q1 2025 | 33.51M | $7.0B | +1.53% |
| Q4 2024 | 33.98M | $6.0B | +1.24% |
| Q3 2024 | 33.21M | $6.6B | +1.36% |
| Q2 2024 | 33.19M | $5.7B | +1.25% |
| Q1 2024 | 31.30M | $5.7B | +1.29% |
| Q4 2023 | 30.30M | $4.7B | +1.16% |
| Q3 2023 | 31.98M | $4.8B | +1.31% |
| Q2 2023 | 32.55M | $4.4B | +1.17% |
| Q1 2023 | 35.71M | $5.7B | +1.62% |
| Q4 2022 | 36.71M | $5.9B | +1.79% |
| Q3 2022 | 36.19M | $4.9B | +1.60% |
| Q2 2022 | 26.30M | $4.0B | +1.25% |
| Q1 2022 | 17.08M | $2.8B | +0.68% |
| Q4 2021 | 18.01M | $2.4B | +0.54% |
| Q3 2021 | 19.01M | $2.1B | +0.48% |
| Q2 2021 | 18.69M | $2.1B | +0.49% |
| Q1 2021 | 20.22M | $2.2B | +0.54% |
| Q4 2020 | 37.92M | $4.1B | +1.05% |
| Q3 2020 | 40.80M | $3.6B | +1.07% |
| Q2 2020 | 46.10M | $4.5B | +1.43% |
| Q1 2020 | 49.23M | $3.8B | +1.47% |
| Q4 2019 | 86.60M | $7.7B | +2.30% |
| Q3 2019 | 100.61M | $7.6B | +2.50% |
| Q2 2019 | 110.12M | $8.0B | +2.54% |
| Q1 2019 | 146.51M | $11.8B | +3.74% |
| Q4 2018 | 173.57M | $16.0B | +5.58% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Capital Research Global Investors’s full portfolio or all institutional holders of ABBV.